RNA Biotechnology

Biotechnology
MRNA Vaccines
RNA Biotechnology
Trade Of The Day

Top mRNA Biotech Stock To Buy Now

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases

Read More
Biopharmaceuticals
Daily Rundown
Dry Bulk Shipping
Immunotherapies
MRNA Vaccines
RNA Biotechnology
Shipping Transportation

Shipping, RNA Vaccines, Biotech, Construction, Immunotherapies

Grindrod Shipping Holdings Ltd. (GRIN) Grindrod Shipping Holdings Ltd., an international shipping company, owns, charters-in, and operates a fleet of dry bulk carriers and tankers worldwide. It operates a fleet of 23 owned dry bulk carriers and 8 long-term chartered-in dry bulk carriers that transport a range of bulk and breakbulk commodities, including ores, coal, […]

Read More
Biotech
Cancer
Cancer Biopharmaceuticals
Coronavirus
COVID-19
Dividends
Economy
Fibonacci Retracement
Fundamental Analysis
HeathCare
Immunology Biopharmaceutical
Immunotherapies
Pharmaceuticals
RNA Biotechnology
Technical Analysis
Tumor-Specific Cancer Immunotherapies
Vaccines
Value Investing
Value Stocks

PFE is down about 20% in the last three months, and that’s a good thing for value-focused investors

As recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]

Read More
Bookstores
Daily Rundown
Ingestible Insulin Capsules
Liquefied Natural Gas
RNA Biotechnology

RNA Biotech, Ingestible Insulin Capsule, PLxGuard, Liquified Natural Gas, Bookstores

Moderna, Inc. (MRNA) Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising prophylactic […]

Read More
X